Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

Celyad to Participate in Upcoming September 2019 Conferences

Celyad to Participate in Upcoming September 2019 Conferences

Discover our news

Upcoming events

Discover all events

a

Press contacts

Celyad

Anne Moore, VP Corporate Strategy

+32 (0)10 39 41 58

LifeSci Advisors

Sara Zelkovic

Ulysse Communication (Europe)

Bruno Arabian